Michael Bailey

CEO

Equibles does not estimate personal net worth.

About Michael Bailey

Michael Bailey is recorded as CEO at Verastem, Inc. (VSTM) since January 1, 2027. Verastem, Inc. reported in an 8-K filed October 14, 2026 that Michael Bailey was appointed President and Chief Executive Officer, effective January 1, 2027. Verastem, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Verastem, Inc. includes Brian M. Stuglik (CEO), Daniel Paterson (CEO and Board Member), Robert Forrester (CEO) and 7 others.

“In connection with the retirement of Mr. Paterson, Michael Bailey, 61, will be appointed to the position of President and Chief Executive Officer as of the Effective Date.”

Verastem, Inc. Form 8-K, filed October 14, 2026 · Read the filing

Affiliation history

Verastem, Inc. (VSTM)
CEO

SEC 8-K

Current
2027-01-01–present

Company network

Verastem, Inc.

VSTM

Current role

Biotechnology · Healthcare

CEO

2027-01-01–present

Leadership on record at Verastem, Inc.

Brian M. Stuglik CEO
Daniel Paterson CEO, Board Member
Robert Forrester CEO
Matthew E. Ros COO
Anil Kapur Board Member
John Johnson Board Member
Lesley Solomon Board Member
Michelle Robertson Board Member
Paul Bunn Board Member
Robert Gagnon Board Member

Recent activity

Executive change Appointed: President and Chief Executive Officer Verastem, Inc. (VSTM)
2027-01-01